Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Palmar Plantar Erythrodysesthesia”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Large-scale testing (Phase 3)UnknownNCT05327751
What this trial is testing

Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer

Who this might be right for
Hand and Foot SyndromeErythrodysesthesia SyndromeHFS+1 more
Tanta University 44
Large-scale testing (Phase 3)Study completedNCT00245050
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganEndometrial Cancer+3 more
Case Comprehensive Cancer Center 34
Large-scale testing (Phase 3)Study completedNCT03612011
What this trial is testing

Efficacy of the Cosmetic Product "Onco-Repair" on Grade 2 Hand Foot Syndrome

Who this might be right for
Grade 2 Hand-foot Syndrom
Quanta Medical 72
Not applicableLooking for participantsNCT06441513
What this trial is testing

The Preventive Effect of Chemotherapy-induced Hand-foot Syndrome

Who this might be right for
Cancer
Peking University Third Hospital 130
Not applicableStudy completedNCT07177560
What this trial is testing

Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)

Who this might be right for
Colorectal CancerGastric Cancer (GC)Capecitabine+1 more
Gazi University 151
Not applicableStudy completedNCT06586073
What this trial is testing

Topical Cosmetic Products for Hand and Foot Syndrome

Who this might be right for
Hand Foot Skin Syndrome
Dermophisiologique s.r.l 53
Early research (Phase 1)Study completedNCT01219023
What this trial is testing

Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil

Who this might be right for
Hand Foot SyndromePalmar Plantar Erythrodysesthesia
Duke University 10
Not applicableNot Yet RecruitingNCT07501442
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of Uracil 0,5% Plasters in Oncology Patients Affected by Hand-foot Syndrome (HFS)

Who this might be right for
HFS
Wooshin Labottach Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT01609166
What this trial is testing

Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome

Who this might be right for
Hand-foot Syndrome
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 60
Large-scale testing (Phase 3)Study completedNCT00446147
What this trial is testing

Study of Pyridoxine for Hand-Foot Syndrome

Who this might be right for
Hand-foot Syndrome
Asan Medical Center 389
Not applicableStudy completedNCT04592731
What this trial is testing

Acetylated Natural Nucleotides in Treating Hand-foot Syndrome

Who this might be right for
Hand-foot Syndrome
Nan xu 21
Not applicableNo Longer AvailableNCT01626781
What this trial is testing

A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer

Who this might be right for
the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With Capecitabine
AIO-Studien-gGmbH
Testing effectiveness (Phase 2)WithdrawnNCT01097850
What this trial is testing

Topical Henna Preparation for the Treatment of Hand Foot Skin Syndrome

Who this might be right for
Hand Foot Skin Syndrome
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT00751101
What this trial is testing

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityPalmar-plantar Erythrodysesthesia
University of California, San Francisco 24
Not applicableUnknownNCT04132713
What this trial is testing

Study on Skin Microbiome of HFS

Who this might be right for
Microbiota
First Affiliated Hospital of Harbin Medical University 50
Not applicableStudy completedNCT00746694
What this trial is testing

Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)

Who this might be right for
Ovarian NeoplasmsBreast NeoplasmsParesthesia
Merck Sharp & Dohme LLC 154
Testing effectiveness (Phase 2)Study completedNCT00213993
What this trial is testing

Topical Antiperspirant for Hand-Foot Syndrome

Who this might be right for
Palmar-plantar Erythrodysesthesia
University of Wisconsin, Madison 14
Not applicableLooking for participantsNCT06639178
What this trial is testing

Effectiveness of an N-acetylcysteine and Urea-based Cream in Prevention of Capecitabine-induced HAND-foot Syndrome in Breast Cancer Patients

Who this might be right for
Breast Cancer
Centro di Riferimento Oncologico - Aviano 25
Testing effectiveness (Phase 2)Study completedNCT05641246
What this trial is testing

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

Who this might be right for
Hand and Foot Syndrome
German University in Cairo 86
Large-scale testing (Phase 3)Ended earlyNCT00486213
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Who this might be right for
Dermatologic ComplicationsPalmar-plantar ErythrodysesthesiaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Centre, Singapore 210
Load More Results